These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Elevated vascular endothelial growth factor in systemic sclerosis. Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453 [TBL] [Abstract][Full Text] [Related]
5. Assessment of elevated pentraxin 3 levels in systemic sclerosis: comment on the article by Shirai et al. Agilli M; Ekinci S Arthritis Rheumatol; 2015 May; 67(5):1408-9. PubMed ID: 25604348 [No Abstract] [Full Text] [Related]
6. Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. Furuse S; Fujii H; Kaburagi Y; Fujimoto M; Hasegawa M; Takehara K; Sato S J Rheumatol; 2003 Jul; 30(7):1524-8. PubMed ID: 12858452 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis. Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367 [TBL] [Abstract][Full Text] [Related]
9. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis. Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis. Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281 [TBL] [Abstract][Full Text] [Related]
11. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers. Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314 [TBL] [Abstract][Full Text] [Related]
12. The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus. Tasci I; Erdem G; Tapan S Diabetes Res Clin Pract; 2009 Nov; 86(2):e37-8. PubMed ID: 19766342 [No Abstract] [Full Text] [Related]
13. Defective vasculogenesis in systemic sclerosis. Kuwana M; Okazaki Y; Yasuoka H; Kawakami Y; Ikeda Y Lancet; 2004 Aug 14-20; 364(9434):603-10. PubMed ID: 15313361 [TBL] [Abstract][Full Text] [Related]
14. Decreased serum IL-7 levels in patients with systemic sclerosis. Makino T; Fukushima S; Wakasugi S; Ihn H Clin Exp Rheumatol; 2009; 27(3 Suppl 54):68-9. PubMed ID: 19796566 [No Abstract] [Full Text] [Related]
15. Current concepts in normal and defective angiogenesis: implications for systemic sclerosis. Mulligan-Kehoe MJ; Simons M Curr Rheumatol Rep; 2007 May; 9(2):173-9. PubMed ID: 17502049 [TBL] [Abstract][Full Text] [Related]
16. Angiogenic activity of sera from patients with systemic autoimmune diseases in relation to clinical, radiological, and functional pulmonary status. Zielonka TM; Demkow U; Zycinska K; Filewska M; Korzeniewska M; Radzikowska E; Bialas-Chromiec B; Kus J; Wardyn KA; Skopinska-Rozewska E J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():791-800. PubMed ID: 19218706 [TBL] [Abstract][Full Text] [Related]
17. Progress in research into systemic sclerosis. Kahaleh B Lancet; 2004 Aug 14-20; 364(9434):561-2. PubMed ID: 15313340 [No Abstract] [Full Text] [Related]